Earnings Releases·Nov 5, 2026, 4:04 PM ET

Nutex Health — Third Quarter 2026 Earnings Summary

**Financial Results:** Nine-month net income rose to $152.9 million ($21.50 EPS) from $59.0 million ($8.87 EPS) in 2025, driven by a $113.2 million reduction in stock-based compensation and a $25.0 million non-cash expense adjustment; however, Q3 net income declined to $40.2 million ($5.71 EPS) from $55.4 million ($7.76 EPS) in 2025, while nine-month revenue fell 10.9% to $644.9 million and Q3 revenue dropped 18.7% to $217.6 million.
**Operational Metrics:** Hospital division patient visits increased 10.2% year-over-year for the nine months and 18.1% for the quarter, with same-hospital visits up 6.3% and 12.4% respectively, despite revenue declines attributed to favorable prior-year collection data adjustments and regulatory uncertainty under the No Surprises Act.
**Balance Sheet & Cash Flow:** The company ended the period with $249.9 million in cash and $34.2 million in long-term debt; operating cash flow for the nine months was $188.1 million (up from $177.7 million in 2025), while $50.7 million was utilized for stock repurchases and retirements.
**Future Outlook:** Management anticipates a strong finish to 2026 with the opening of two new hospitals in Q4, citing a robust de novo development pipeline and growing patient volumes across the network.